K Hotta Selected Research

K Hotta Research Topics

Disease

11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 05/2000
9	Neoplasms (Cancer) 01/2022 - 01/2000
8	Obesity 12/2001 - 01/2000
7	Insulin Resistance 12/2001 - 07/2000
4	Coronary Artery Disease (Coronary Atherosclerosis) 07/2001 - 06/2000
3	Disease Progression 01/2021 - 11/2005
3	Retinal Detachment (Retinal Detachments) 03/2006 - 01/2000
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 05/2009
2	Lung Neoplasms (Lung Cancer) 02/2011 - 11/2005
2	Hypertension (High Blood Pressure) 12/2001 - 01/2000
2	Glucose Intolerance 12/2001 - 05/2001
2	Vascular Diseases (Vascular Disease) 09/2001 - 03/2001
2	Atherosclerosis 09/2001 - 02/2001
2	Type 2 Diabetes Mellitus (MODY) 05/2001 - 05/2001
2	Cataract (Cataracts) 03/2001 - 01/2000
2	Retinal Perforations 03/2001 - 01/2000
2	Proliferative Vitreoretinopathy 03/2001 - 01/2000
2	Tibial Meniscus Injuries 03/2001 - 01/2000
2	Adenocarcinoma 01/2001 - 09/2000
2	Adenoma (Adenomas) 01/2001 - 09/2000
1	Hypotension (Low Blood Pressure) 12/2018
1	Adenocarcinoma of Lung 01/2017
1	Chronic Renal Insufficiency 04/2012
1	Chronic Kidney Failure (Chronic Renal Failure) 04/2012
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2009
1	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2006
1	Burns 03/2006
1	Polymyositis 03/2006
1	Infections 01/2004
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2004
1	Neoplasm Metastasis (Metastasis) 10/2003
1	Body Weight (Weight, Body) 09/2001
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2001
1	Ulcer 05/2001
1	Hyperinsulinism (Hyperinsulinemia) 05/2001
1	Hypoadiponectinemia 05/2001
1	Stomach Ulcer (Gastric Ulcer) 05/2001
1	Ischemia 03/2001

Drug/Important Bio-Agent (IBA)

8	AdiponectinIBA 09/2001 - 06/2000
6	MucinsIBA 05/2001 - 01/2000
5	Monoclonal AntibodiesIBA 03/2024 - 01/2000
5	Proteins (Proteins, Gene)FDA Link 07/2001 - 01/2000
3	Gefitinib (Iressa)FDA Link 08/2022 - 11/2005
3	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 12/2001
3	PlatinumIBA 01/2022 - 12/2004
3	Glucose (Dextrose)FDA LinkGeneric 12/2001 - 01/2000
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2001 - 09/2000
3	AntibodiesIBA 01/2001 - 01/2000
2	ErbB Receptors (EGF Receptor)IBA 03/2024 - 01/2021
2	Retinaldehyde (Retinal)IBA 03/2006 - 03/2001
2	Insulin (Novolin)FDA Link 12/2001 - 09/2001
2	ParaffinIBA 05/2001 - 02/2000
2	Blood Proteins (Serum Proteins)IBA 02/2001 - 09/2000
2	CarbohydratesIBA 09/2000 - 01/2000
2	EnzymesIBA 05/2000 - 01/2000
2	ImmunosorbentsIBA 05/2000 - 01/2000
1	LigandsIBA 03/2024
1	necitumumabIBA 03/2024
1	Anaplastic Lymphoma KinaseIBA 01/2022
1	tremelimumabIBA 01/2022
1	alectinibIBA 01/2022
1	IpilimumabIBA 01/2022
1	CrizotinibIBA 01/2022
1	durvalumabIBA 01/2022
1	NivolumabIBA 01/2022
1	Etoposide (VP 16)FDA LinkGeneric 01/2022
1	Carboplatin (JM8)FDA LinkGeneric 01/2022
1	B7-H1 AntigenIBA 01/2022
1	Docetaxel (Taxotere)FDA Link 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 12/2018
1	AlbuminsIBA 12/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	AfatinibIBA 01/2017
1	Cell-Free Nucleic AcidsIBA 01/2017
1	Coloring Agents (Dyes)IBA 03/2006
1	ArgonIBA 03/2006
1	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2006
1	Platinum Compounds (Compounds, Platinum)IBA 12/2004
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2004
1	OF 743IBA 10/2003
1	Vinorelbine (Navelbine)FDA LinkGeneric 12/2001
1	Troglitazone (Rezulin)FDA Link 12/2001
1	Triglycerides (Triacylglycerol)IBA 12/2001
1	Cysteine (L-Cysteine)FDA Link 07/2001
1	Acetic Acid (Vinegar)FDA LinkGeneric 05/2001
1	CaspasesIBA 03/2001

Therapy/Procedure

6	Drug Therapy (Chemotherapy) 01/2022 - 12/2001
3	Vitrectomy 03/2001 - 01/2000
2	Chemoradiotherapy 08/2022 - 01/2021
2	Therapeutics 01/2021 - 01/2004
2	Kidney Transplantation 04/2012 - 04/2012
2	Scleral Buckling 03/2001 - 01/2000
1	Radiotherapy 01/2021
1	Plasmapheresis 12/2018
1	Plasma Exchange 12/2018
1	Immunotherapy 11/2009
1	Lasers (Laser) 03/2006
1	Light Coagulation 03/2006
1	Aftercare (After-Treatment) 10/2003